Companies / Theriva Biologics, Inc.

Theriva Biologics, Inc.

NYSE: TOVXCIK 894158ROCKVILLE, MD

Financials · FY2011

Revenue$0
Net income$-23.74M
Total debt$1.73M
Cash$11.34M
Diluted EPS$-2.08
Shares outstanding45.9M

Ownership

45.9M shares outstanding · as of Aug 7, 2026
3.3%Institutions
Ownership
Institutions3.28%1,506,789
Public float96.72%44,385,879

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Kraws Jeffrey JDirector
——
Monahan John JDirector
——
Shallcross Steven aCEOCEO and CFO · Director
——
Wolf Jeffrey AlanDirector
——

Institutional holders 22

View all →
HolderValue% of shares
Geode Capital Management, LLC$88.2K0.98%
Vanguard Group Inc$53.7K0.56%
Morgan Stanley$42.1K0.44%
UBS Group AG$40.2K0.42%
Ikarian Capital, LLC$23.6K0.24%
Two Sigma Securities, LLC$9.0K0.09%
DRW Securities, LLC$8.8K0.09%
XTX Topco Ltd$8.3K0.09%
StoneX Group Inc.$7.8K0.08%
Barclays PLC$6.9K0.07%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 5, 2026Wolf Jeffrey Alan
Director
GrantStock Options (right to buy)—+75K
75,000
0.16% of shares
low
Jan 5, 2026Kraws Jeffrey J
Director
GrantStock Options (right to buy)—+75K
75,000
0.16% of shares
low
Jan 5, 2026Shallcross Steven a
CEO
GrantStock Options (right to buy)—+475K
475,000
1.04% of shares
low
Jan 5, 2026Monahan John J
Director
GrantStock Options (right to buy)—+75K
75,000
0.16% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
TOVXCommon StockEquity87164U508BBG000BV6QX8